logo
Australian polar adventurer turned astronaut Eric Philips takes part in historic SpaceX mission

Australian polar adventurer turned astronaut Eric Philips takes part in historic SpaceX mission

Sitting under the night sky at Eric Philips' home in Victoria's high country, it is hard not to feel close to the cosmos.
"The stars are always alluring and the place of dreams, right?" he said.
"If anywhere you can let your imagination run wild it's up there, but for me it's no longer imagination.
"That's the bizarre thing, it's reality now."
Mr Philips is no stranger to extreme environments. As one of the world's leading polar experts, he and friend John Muir were the first Australians to ski to both the North and South Poles.
When 7.30 caught up with him he had just returned from his boldest adventure to date – private space travel.
Mr Philips became the first Australian to fly into space under the Australian flag as part of a chartered SpaceX mission in early April.
The mission was privately funded and commanded by former Chinese national Chun Wang, a crypto billionaire, now a citizen of Malta, who Mr Philips guided on a ski trip in the Arctic Circle in 2023.
"It's the most phenomenal tip a client could give me."
Mr Wang purchased the chartered spaceflight from Elon Musk's SpaceX for an undisclosed figure.
Mr Philips has described Mr Wang as a "denizen of the universe".
"He considers himself nomadic because he travels the world, visiting every country that he can and is a Bitcoin entrepreneur, that's how he made his money in order to pay for this mission," he said.
The mission, titled 'Fram2' after an early Norwegian polar research ship saw the crew become the first humans to complete an orbit of the North and South Poles.
Norwegian filmmaker Jannicke Mikkelsen and German polar scientist Rabea Rogge were also on board the 'Dragon' capsule.
"It is an autonomous craft. Everything is planned by SpaceX, by ground control, mission control. It's uploaded into the system of the Dragon capsule and it will do everything from launch through to splashdown," Mr Philips said.
After a year of training the crew launched from the historic Cape Canaveral in Florida on April 1.
Their launch took them beyond the Kármán line, the boundary line 100 kilometres above sea-level where the atmosphere ends and outer space begins.
"It's the most immersive experience you could possibly imagine."
During the three-and-a-half-day mission in microgravity the crew completed 55 orbits of Earth.
"You see all of Earth, all of Earth below you … you can turn around in that dome and you are seeing the entire horizon," Mr Philips said.
"That feeling, I knew that would be profound in some way but I didn't know that it would affect me so emotionally.
"Looking at Earth from that perch and knowing that we have a pretty rough history of treating our planet the way we do, and with the current bickering and squabbling amongst our people down on Earth, that if everyone could have the opportunity to see this incredible planet from above, I think it would give people much more perspective over their lives and how we should treat our fellow citizens and the Earth itself."
While hurtling around the planet the crew conducted 22 research projects designed to pave the way for human long-haul space flight, including the first X-ray in space and the first attempt at growing mushrooms.
"There's a big push at the moment to get to Mars and perhaps to build a Mars colony and for humans to inhabit that, so these research projects all contribute to this next phase of human life," Mr Philips said.
Despite being in a hostile environment, Mr Philips said at no point did he feel close to death, except for when their spaceship re-entered the Earth's atmosphere.
"Then you feel gravity start to take over and you are plummeting down to Earth at more than 500kph in absolute freefall," he said.
After a successful splashdown off the coast of California, the crew of Fram2 accomplished one final piece of history, becoming the first astronauts to complete an 'unassisted egress', an exit of the spacecraft without additional medical and operational assistance.
Just days after Mr Philip's mission another group took to the sky with private space company Blue Origin, owned by billionaire Jeff Bezos.
An all-female crew, which included his fiancee Lauren Sanchez and pop singer Katy Perry, spent 11 minutes above the Earth.
Space travel is currently extremely expensive for both civil and private space agencies, but Mr Philips believes it will become more accessible.
He said SpaceX is developing a craft that will take hundreds of people into space.
"You can literally board that spaceship like you board an Airbus or a Boeing aircraft and fly internationally. That is in the not-too-distant future, and I can certainly see that happening," he said.
"That will ultimately bring the cost down and make space travel available to a wide group of people."
Now aged 62, Mr Philips said his celestial experience with SpaceX has ignited his passion for the universe.
"There is no question that I look at the night sky now from a different perspective and an acute longing to be back up there, it was such an intoxicating experience," he said.
"If I had the opportunity to go back tomorrow, I would take it."
Watch 7.30, Mondays to Thursdays 7:30pm on ABC iview and ABC TV
Do you know more about this story? Get in touch with 7.30 here.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Health Check: Stuck in biotech's ‘death zone', Opthea and Patrys check in on the sat phone
Health Check: Stuck in biotech's ‘death zone', Opthea and Patrys check in on the sat phone

News.com.au

timean hour ago

  • News.com.au

Health Check: Stuck in biotech's ‘death zone', Opthea and Patrys check in on the sat phone

Opthea and Patrys report they are still alive after failing to reach the summit, but the line's a bit crackly Renerve in Berkeley tie up for soft tissue repair Imugene furthers trial of 'off Broadway' asset With the Everest climbing season at its peak, the news from the 'death zone' is that the stricken Opthea is still alive. Can the company execute an organised descent? In a corporate update today, the eye disease drug developer said it was unable to clarify things until it had finished negotiating with its funders. So perhaps more of a non-update from camp four, although radio comms that high up can be patchy. But the company did announce that four of its eight board members would hang up their crampons. The departees are Dr Julia Haller, Dr Susan Orr, Quinton Oswald and Anshul Thakral. That leaves chairman Jeremy Levin, Kathy Connell, Lawrence Gozlan and Sujal Shah to battle on with depleted oxygen tanks. On March 24 the company reported the first of its two phase III eye disease trials failed to hit its primary endpoints. The second one fared no better and both have been abandoned in the blizzard. The studies focused on the hard-to-treat wet aged-related macular degeneration. Investors are asking how much of Opthea's residual cash of US$113 million ($176 million) will remain, if any. Under a development funding agreement (DFA), the company could be in hock to a cabal of investors for up to US$680 million. Opthea says it remains in 'active negotiations with its DFA investors … to explore possible options to deliver the best outcome for the company and its shareholders." Opthea shares were suspended on March 17 at 60 cents, for an illusory $738 million market cap. In reality, the shares potentially are worth nothing. The company promises a briefing when the DFA discussions are finalised. Stay tuned Meanwhile, Patrys' corporate update tomorrow should show whether the company has abandoned all attempts to reach the summit. Remember Patrys? The company was to launch a first-in-human phase I trial for its antibody cancer candidate, PAT-DX1. In October last year, the company said safety testing showed unacceptable margins of tolerance, so the program was canned. Patrys is forging ahead with a less favoured program, Pat-DX3 (not sure what happened with PAT-DX2). The company also intended to partner the DX-1 program. Patrys shares trade at a fraction of a cent, so are at base camp. Perhaps they can scale great heights again with the help of a decent Sherpa, er, partner. Renerve enrolls at Berkeley Nerve regeneration outfit Renerve has joined with the San Francisco based Berkeley Biologics to develop and commercialise two tissue-based products. Renerve recently started selling its FDA-cleared flagship product, the Nervalign Nerve Cuff, in the US. The company also has a nerve graft product. One initial product from the collaboration addresses the need for human dermal tissue (deeper layers of the skin often sourced from donors). The other provides amniotic tissue products, which are known for their regenerative and healing properties. 'These products have application in the medical procedures that Renerve seeks to address with its current and future Nervealign products,' Renerve says. 'Accordingly, their sale will be a natural extension of Renerve's current sales activities, using the same sales network and targeting the same surgeon and hospital customers.' The parties target the first product for a September quarter launch, with the second due on market before the year is out. Renerve will elaborate in an investor webinar scheduled for 11 am tomorrow. Imugene opens cancer site for 'off Broadway' program Immune-oncology drug developer Imugene has opened its first Australian trial site for a clinical study that hones in on a rare-ish subset of colorectal (bowel) cancer. That target is called mismatch repair-deficient/microsatellite instability high colorectal cancer, which accounts for 15% of all bowel tumours. The drug candidate is called PD1-Vaxx, which is all about inducing the body to produce polyclonal antibodies that block the PD-1 signalling pathway. This hopefully restores the immune system's ability to detect and destroy cancer cells. The trial is part of B-cell immunotherapy platform 'deprioritised' by Imugene, in favour of more show-stopping stuff such as Car-T therapies. But sometimes the off-Broadway stuff can prove the box office hit. The investigator-led phase II study is being carried out by Cancer Research UK Southampton Clinical Trials, the Royal Surrey Hospital NHS Foundation Trust and the Australasian Gastro-Intestinal Trial Group. The study's primary objective is the degree to which tumours reduce with PD1-Vaxx, pre surgery. Makes sense … Meanwhile, Imugene will seek shareholder consent to consolidate its stupendous 7.4 billion on issue, to around 200 million. Meanwhile, Inoviq (ASX:IIQ) shares this morning vaulted more than 30% after the company updated a US oncology powwow about its "breakthrough" ovarian cancer test results. As we noted already, Inoviq shares had moved already, but on 'old news' – fake news? – rather than today's 'new news'. The results were aired at the American Society of Clinical Oncology's get together in Chicago.

Cruz Hewitt ‘valiant' in opening round French Open defeat
Cruz Hewitt ‘valiant' in opening round French Open defeat

News.com.au

time3 hours ago

  • News.com.au

Cruz Hewitt ‘valiant' in opening round French Open defeat

Cruz Hewitt has given a glimpse of his old man's famous fighting spirit in his first round match at the French Open. The son of Lleyton Hewitt had stormed through qualifying to secure a spot in the junior boys' tournament at Roland Garros. Watch every game of The 2025 FIFA Club World Cup LIVE on Kayo Sports | New to Kayo? Get your first month for just $1. Limited time offer. Cruz took on Italian Pierluigi Basile overnight on Sunday in a hard fought match, ultimately going down 7-6 (7-4) 5-7 6-3. A very tight first set was claimed by Basile, who is two years older than Hewitt and higher in the world junior rankings. But the 16-year-old Aussie fought back to win the second set on Court No. 4, with Cruz revving up the crowd with a gritty performance reminiscent of his dad. Basile had too much firepower and went on to win the third set, claiming the marathon match in two hours and 10 minutes as Cruz fell short of the second round. The teenager made the second round of the Australian Open juniors in January, where he lost in the first round in qualifiers for the men's tournament. Tennis Australia said Hewitt, the world No. 41 junior, was 'valiant' in his first round loss, recording 10 aces in the defeat. There has been mixed success for Australia's contingent at the French Open, with Alex de Minaur losing in five sets in the second round to Alexander Bublik. Alexei Popyrin progressed to the fourth round before suffering a 6-3 6-3 6-3 defeat to American Tommy Paul. In the women's draw, newly adopted Australia Daria Kasatkina takes on Russian teen sensation Mirra Andreeva in the fourth round on Monday night (AEST). Another Aussie, Ty Host takes on the USA's Benjamin Willwerth in their boys' singles first round. In the girls' singles first round, Australia's Emerson Jones is the top seed and will take on American qualifier Capucine Jauffet. Jones, who has been mentioned as Ash Barty's successor, is aiming to reach her third junior grand slam final after reaching the semifinals of the Australian Open. Australian boys' No. 2 Ty Host opens his account against reigning Australian Open boys' finalist Benjamin Willwerth. Host hopes to become the first Australian boys' singles champion in France since Popyrin in 2017.

Best early EOFY travel deals for 2025
Best early EOFY travel deals for 2025

News.com.au

time4 hours ago

  • News.com.au

Best early EOFY travel deals for 2025

June 30 is coming up quick and fast, which can only mean two things: time to sort out your tax and time to shop the End of Financial Year Sales (EOFY). Let's face it, we all know which is more enjoyable. Traditionally regarded as a time to shop for tax deductible work items, EOFY has lately become the perfect excuse for any and all to host a sale - travel brands included. This year we're already seeing Flight Centre axe prices by up to 60 per cent in its Big Red Sale. Extended until June 6 (though we're betting they'll extend again!) flights, cruises, tours and accommodation worldwide have all been given a mighty price slash. Highlights that are sure to sell out soon include $1310 return flights to Rome on Air China, $599 return flights to Singapore on Malaysia Airlines, 2-for-1 Premium European River cruise from Budapest and eight nights at the adults-only Kamala Beach Resort in Phuket from $330 per person. Today, Amazon joined in the fun with a Mid-Year sale stocked to the gills with heavily discounted tech, toys and homewares. If you've been eyeing a robovac for way too long, the ECOVACS DEEBOT T20e Omni is down to $799 (was $1999) while campers (including backyard ones) can snap up a XuanPad Mini Projector for outdoor movie nights for $128.99 (down from $199.99). For suitcases, American Tourister and Antler have both taken up to 50 per cent off their bestsellers. Close on their heels Samsonite and Myer are running 40 per cent off luggage sales, while The Iconic has plucked out some best-selling American Tourister, Samsonite, Kathmandu and Cobb & Co collections and docked hundreds of dollars off each. After those precious tax deductibles? HP is slinging half-price laptops, Lenovo is inching ahead with 51 per cent off selected laptops and tablets and Myer's got 15 per cent off tech gear like earbuds, speakers and headphones. With the End of Financial Year sales running throughout June, we've got it on good authority that there will be lots more deals coming in the new weeks. We'll update this story as they drop. In the meantime, here are the best early EOFY sales that you can shop today. Jump to: Please note: Prices are correct and products in stock at time of publishing. We'll do our best to keep this story updated, but be aware products move fast during sales events. BEST EARLY END OF FINANCIAL YEAR DEALS Myer Flight Centre The Iconic Up to 60 per cent off end of season sale 50 per cent off selected travel and luggage Smilie Amazon Australia Antler Up to 50 per cent off luggage LATRAVLA 20 per cent off silk pillow wraps. Use code SLEEPWELLTRAVEL The Good Guys American Tourister Mid Year Sale: Up to 50 per cent off Samsonite BEST EARLY END OF FINANCIAL YEAR TRAVEL SALES Luxury Escapes Up to 47 per cent off The Star Grand Hotel, two nights from $599 per room. Includes daily breakfast, $50 dining credit, late checkout and free parking. Up to 50 per cent off Rydges Resort Hunter Valley, two nights from $429 per room. Includes daily breakfast, nightly cocktails, wine tastings and discounted spa treatments and golfing. Up to 62 per cent off The Mulia, five-nights from $2899 per suite. Includes daily breakfast, daily lunch or dinner, two hours of free-flow cocktails, afternoon tea and canapes, beach club access, kids' club access and 24-hour butler service. Up to 71 per cent off The Haven Khao Lak, seven nights from $949 per room. Includes daily breakfast and lunch or dinner, two hours of daily free-flow cocktails, massages, shuttle and late checkout. Includes daily breakfast, dining credit and daily cocktails. Up to 65 per cent off Grand Mirage Resort & Thalasso Bali, six nights from $2399 per room. All-inclusive package, with unlimited dining, free-flow drinks and some massages. Babybee WAS Travel Insurance 10 per cent off insurance policies when you use the code WISESILENT10 Escape Deals Strandbags Up to 50 per cent off selected handbags Save up to 20 per cent on stays worldwide. Book by September 30, 2025. Expedia At least 20 per cent off last-minute weekend stays Mix & Match Skyscanner BEST EOFY TECH DEALS Lenovo HP Up to 45 per cent off selected laptops Samsung BEST EOFY FASHION DEALS Boody Up to 70 per cent off sale stock Up to 25 per cent off bundles 15 per cent off your first order when you sign up The Oodie Up to 50 per cent off sitewide Lorna Jane $60 Black Lotus Leggings Up to 40 per cent off selected styles Lululemon Mid-Year Sale Step One Buy 8, get 10 free Calvin Klein Up to 50 per cent off sitewide Witchery Up to 50 per cent off the end of season sale Country Road Up to 50 per cent off selected styles Adidas 40 per cent off the end of season sale Nine West $50 off full priced shoes Coach Outlet BEST HEALTH AND BEAUTY DEALS Bescher Beauty Oz Hair and Beauty Up to 75 per cent off sale Priceline Lovehoney 20-50 per cent off sale BEST EOFY HOME DEALS Yoto Dyson $550 off the Dyson V15s Detect Submarine Complete vacuum, $1099 (down from $1649) $150 off the Dyson Airstrait Straightener and Dryer (Ceramic Pink), $599 (down from $749) Sheridan 40 per cent off Sheridan Sheridan Outlet Everything under $199 Temple & Webster Up to 40 per cent off the warehouse sale Canningvale Mocka FREQUENTLY ASKED QUESTIONS ABOUT THE END OF FINANCIAL YEAR SALES What are End of Financial Year sales? The End of Financial Year sale, sometimes referred to as EOFY, Mid-Year sale and Stocktake Sale, is an annual deals event that typically runs throughout June in the lead-up to the end of financial year on June 30. In Australia, it's regarded as one of the biggest sales events of the year and features everything from whitegoods and tech to homewares and travel. How long do the End of Financial Year sales last? The End of Financial Year sales run until June 30, which is the end of the tax year. What are the biggest sales of the year in Australia? While the End of Financial Year sale is arguably the biggest sale during the winter months. Come summer you'll be spoiled for choice with Black Friday (which falls on November 28 this year), Boxing Day (December 26) and Click Frenzy (held during November). - Best luggage brands

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store